Milestone Pharmaceuticals Inc (MIST) — Financial Flexibility Index
Milestone Pharmaceuticals Inc (MIST) has a Financial Flexibility Index of -0.15x as of September 2025. Free cash flow of $-9.81 Million (operating CF $-9.82 Million minus capex $1.98K) represents 0% of total liabilities ($67.25 Million). Check Milestone Pharmaceuticals Inc (MIST) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Milestone Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Milestone Pharmaceuticals Inc across 8 annual periods. See working capital to net assets of Milestone Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Milestone Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Milestone Pharmaceuticals Inc. For the full company profile including market capitalisation, see Milestone Pharmaceuticals Inc (MIST) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.46x | $-28.82 Million | $-28.85 Million | $62.35 Million | ▲ +41.7% |
| 2023 | -0.79x | $-46.31 Million | $-46.42 Million | $58.45 Million | ▲ +87.7% |
| 2022 | -6.42x | $-52.20 Million | $-52.47 Million | $8.13 Million | ▼ -40.0% |
| 2021 | -4.58x | $-33.22 Million | $-33.22 Million | $7.25 Million | ▲ +38.0% |
| 2020 | -7.39x | $-50.63 Million | $-50.73 Million | $6.86 Million | ▼ -23.9% |
| 2019 | -5.96x | $-50.74 Million | $-51.15 Million | $8.51 Million | ▼ -3959.9% |
| 2018 | -0.15x | $-21.04 Million | $-21.05 Million | $143.29 Million | ▼ -11.2% |
| 2017 | -0.13x | $-8.02 Million | $-8.05 Million | $60.71 Million | — |